立方数科（300344）受损投资者尚存索赔机会

Core Viewpoint - The company Lifan Shuke (立方数科) is under investigation by the China Securities Regulatory Commission (CSRC) for alleged violations of information disclosure, with potential implications for investor compensation claims due to false financial reporting [2][4]. Group 1: Investigation and Allegations - On November 28, 2025, Lifan Shuke announced that it is being investigated by the CSRC for suspected violations of information disclosure laws [2][4]. - The CSRC's preliminary notice indicates that the company's annual reports for 2021, 2022, and 2023 contain false records, with the total amount of false reported revenue for 2021 and 2022 reaching 591,582,002.31 yuan, accounting for 50.91% of the total reported revenue for those two years [2][5]. - The company may face mandatory delisting due to serious violations of the Shenzhen Stock Exchange's listing rules, as it has reported false financial indicators for three consecutive years [2][5]. Group 2: Investor Compensation Opportunities - Investors who purchased Lifan Shuke shares between April 25, 2022, and April 29, 2025, and sold or continued to hold the shares after April 29, 2025, may still initiate compensation claims [3][6]. - The law firm Shanghai Jiucheng, led by attorney Xu Feng, is actively pursuing compensation claims for affected investors and has submitted multiple cases to the court for filing [3][6]. - The law firm has a history of successfully representing investors in similar cases, with no fees charged to investors unless compensation is awarded [6].